Archives for May 25, 2011

← 2011

Goodwin Biotechnology and Rafagen team on cell line manufacturing

By Alexandria Pesic

Florida-based contract manufacturing organisation (CMO), Goodwin Biotechnology (GBI), has entered into an agreement with protein and monoclonal antibody drug developer, Rafagen, to provide cell line engineering and biological contract manufacturing services.